What is TransMedics Group Inc?
, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company provides Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 3.17B, and a P/E ratio of 24.9x.
A short list of Medical Devices names that are close enough in size to make side-by-side comparison useful.
| Shares sold | Shares bought | |
|---|---|---|
| 0-3months | 0 | 0 |
| 3-6months | 0 | 0 |
| 6-9months | 616,205 shares $2.4M | 0 |
| 9-12months | 38,920 shares $1.3M | 0 |